Colony Capital Inc (CLNY)

8.5  +0.52 (+6.52%)

After market: 8.18 -0.32 (-3.76%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CLNY. CLNY was compared to 127 industry peers in the Diversified REITs industry. Both the profitability and financial health of CLNY have multiple concerns. CLNY does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

In the past year CLNY has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -15.52%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -140.48%
PM (TTM) -193.24%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

CLNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CLNY has a Debt/Equity ratio of 1.08. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.39% over the past year.
Looking at the last year, CLNY shows a very negative growth in Revenue. The Revenue has decreased by -41.59% in the last year.
Measured over the past years, CLNY shows a quite strong growth in Revenue. The Revenue has been growing by 9.25% on average per year.
EPS 1Y (TTM)37.39%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q26.32%
Revenue 1Y (TTM)-41.59%
Revenue growth 3Y-21.43%
Revenue growth 5Y9.25%
Revenue growth Q2Q-37.79%

3.2 Future

CLNY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.61% yearly.
The Revenue is expected to grow by 2.23% on average over the next years.
EPS Next Y21.74%
EPS Next 2Y37.1%
EPS Next 3Y23.9%
EPS Next 5Y14.61%
Revenue Next Year-20.16%
Revenue Next 2Y-9.7%
Revenue Next 3Y-1.73%
Revenue Next 5Y2.23%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLNY. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CLNY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -14.69

4.3 Compensation for Growth

CLNY's earnings are expected to grow with 23.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.1%
EPS Next 3Y23.9%

1

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.29%, CLNY has a reasonable but not impressive dividend return.
With a Dividend Yield of 1.29, CLNY pays less dividend than the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 1.29%

5.2 History

The dividend of CLNY decreases each year by -22.76%.
CLNY has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-22.76%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

The earnings of CLNY are negative and hence is the payout ratio. CLNY will probably not be able to sustain this dividend level.
DP-4.92%
EPS Next 2Y37.1%
EPS Next 3Y23.9%

Colony Capital Inc

NYSE:CLNY (6/21/2021, 7:04:00 PM)

After market: 8.18 -0.32 (-3.76%)

8.5

+0.52 (+6.52%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.14B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.29%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.52%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -140.48%
PM (TTM) -193.24%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)37.39%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y21.74%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-41.59%
Revenue growth 3Y-21.43%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y